Abstract. Visceral adipose tissue-derived serine protease inhibitor (vaspin) is a novel adipokine with potential insulin-sensitizing properties, which was initially detected in the visceral adipose tissue of genetically obese rats. Previous studies have demonstrated that vaspin exerts a protective effect on arteries undergoing atherosclerosis in vitro, and it has been shown to exert anti-inflammatory and antimigratory effects on vascular smooth muscle cells. Vaspin promotes proliferation and inhibits apoptosis in endothelial cells, and decreases proliferation of the arterial intima under diabetic conditions. In addition, macrophage apoptosis is an important characteristic of atherosclerotic plaque development. In vivo experiments were performed by histological analysis, including Oil Red O, hematoxylin and eosin and Masson's trichrome staining. Mice were injected with lentivirus via the tail vein and tissues were obtained for histological analysis. Cell apoptosis was determined by flow cytometry of Annexin-V/propidium iodide dual staining and terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling assay. Total proteins were extracted and protein expression levels were detected by western blot analysis. The present study aimed to investigate whether vaspin was able to protect against atherosclerotic development in vivo, and to explore the underlying mechanisms of the potential antiatherogenic effects. The results of the current study indicated that vaspin inhibited the progression of atherosclerotic plaques in apoE -/-mice by inhibiting endoplasmic reticulum stress-induced macrophage apoptosis.
Introduction
Visceral adipose tissue-derived serine protease inhibitor (vaspin) was initially detected in the visceral adipose tissue of Otsuka Long-Evans Tokushima Fatty rats (1) . Vaspin is a compensatory adipokine with anti-inflammatory properties that is able to improve insulin sensitivity, as demonstrated by the administration of recombinant human vaspin protein to diet-induced obese mice (1, 2) . In addition, elevated serum vaspin concentrations have been detected in humans with obesity, type 2 diabetes and polycystic ovary syndrome, and a correlation has been identified between vaspin and C-reactive protein levels (3) (4) (5) (6) (7) .
In addition to its ability to ameliorate diabetes, vaspin exerts protective effects on heart disease. For example, low vaspin concentrations correlate with coronary artery disease (CAD) severity and unstable angina pectoris (8) . Previous studies have also demonstrated that vaspin may inhibit endothelial cell apoptosis and attenuate high glucose-stimulated vascular smooth muscle cell (VSMC) proliferation and chemokinesis (9, 10) . Furthermore, vaspin has been reported to stimulate the 78-kDa glucose-regulated protein (GRP78)/murine tumor cell DnaJ-like protein 1 (MTJ-1) complex and subsequent signals, exerting beneficial effects on endoplasmic reticulum (ER) stress-induced metabolic dysfunction (11) . In the cardiovascular system, vaspin acts as a ligand for the cell-surface GRP78/voltage-dependent anion channel (VDAC) complex in endothelial cells, promotes proliferation, inhibits apoptosis, and protects against diabetes mellitus-associated vascular injury (12) .
Macrophage apoptosis is an important characteristic of atherosclerotic plaque development. Particularly in advanced lesions, macrophage apoptosis is a key factor that aggravates advanced plaque necrosis (13) . ER stress has emerged as a general mediator of vascular inflammation and endothelial dysfunction in atherosclerosis, and has been reported to contribute to plaque vulnerability via the induction of macrophage and VSMC apoptosis (14) . ER is the major cellular site for protein folding and trafficking, and is central to numerous cellular functions. Failure of the adaptive capacity of ER results in activation of the unfolded protein response, which can lead to cell pathology and subsequent tissue dysfunction (15) . In pathological settings, prolonged ER stress may trigger apoptosis, either through the functions of inositol-requiring enzyme-1 at the ER or through downstream effectors, including C/EBP-homologous protein (CHOP). Activation of ER stress contributes to macrophage death and subsequent plaque necrosis in advanced atheroma, a process that has widely been accepted as an important factor in atherosclerosis (16) .
It has previously been demonstrated that low vaspin serum concentrations are correlated with recent ischemic events in patients with carotid stenosis (17) . In addition, decreased vaspin serum levels have been detected in asymptomatic patients with CAD (18) . Furthermore, Zhang et al also demonstrated that low vaspin concentrations are correlated with the severity of CAD and acute coronary diseases (19) .
The present study aimed to determine whether the effects of vaspin on plaque progression and morphology in apolipoprotein E (apoE) -/-mice were mediated by inhibition of ER stress-induced apoptotic pathways. In vitro experiments were also performed to examine the role of vaspin in THP-1 macrophages.
Materials and methods
Ethics statement. The experiments outlined in the present study conform to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (20) . All animal procedures were approved by the Animal Care and Use Committees of the Shanghai Tenth People's Hospital (Shanghai, China).
Lentivirus preparation. The vaspin-encoding lentivirus (LV5-mus-vaspin) and control lentivirus (LV5NC) were purchased from Shanghai GenePharma Co., Ltd. (Shanghai, China). The lentiviruses also expressed green fluorescent protein (GFP). Final titers were 1x10 8 TU/ml for LV5-mus-vaspin and 1x10 9 TU/ml for LV5NC. All experiments described in the present study were performed using the same lentiviruses.
Experimental animals. Male apoE -/-mice (age, 6 weeks; n=16) and male C57BL/6 mice (age, 6 weeks; n=8) were obtained from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China) and fed a high cholesterol diet containing 16.6% fat, 10.6% sucrose and 1.3% cholesterol (Shanghai SLAC Laboratory Animal Co., Ltd., Shanghai, China) for 12 weeks. The mice were housed in cages with a 12-h light/dark cycle. The temperature of the animal room was maintained at 23±2˚C and the relative humidity was maintained at 55±15%. All of the animals were provided free access to drinking water and food. The mice were divided into two treatment groups, LV5NC (n=8) and LV-mus-vaspin (n=8). Each mouse was injected with 200 µl lentivirus through the tail vein. Body weight and food intake were monitored every 5 days in both groups. ; cat. no. sc-2042) at 37˚C for 1 h, and then incubated with diaminobenzidine substrate (0.05%; Sigma-Aldrich) for 1-3 min. Specimens were counterstained with hematoxylin and images were captured under a Leica DMI6000 microscope. Three sections from each animal were stained for lesion quantification, which was expressed as a percentage of total lesion area. Data are presented as the mean ± standard error of the mean (SEM).
Cell culture. Human monocytic THP-1 cells were purchased from the Institute of Biochemistry and Cell Biology (Shanghai, China). The cells were cultured in RPMI-1640 medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 2 mM L-glutamine (Gibco; Thermo Fisher Scientific, Inc.) and 10% fetal bovine serum (BSA; Gibco; Thermo Fisher Scientific, Inc.) at 37˚C with 5% CO 2 in a humidified atmosphere (21) . The THP-1 cells were incubated with 100 nM phorbol-12-myristate 13-acetate (PMA; Sigma-Aldrich) for 48 h and allowed to differentiate into macrophages. Prior to incubation with oxidized (ox)-LDL (50 µg/ml; Guangzhou Yiyuan Biotech., Co., Ltd., Guangzhou, China) for 24 or 48 h, the PMA-induced macrophages were treated with vaspin (100 ng/ml; Sigma-Aldrich) for 24 h and harvested for subsequent experiments.
Flow cytometry (FCM) analysis. Apoptosis was evaluated in three independent experiments using an Annexin V Apoptosis Detection kit (Roche Diagnostics Operations, Indianapolis, IN, USA). Macrophages (1x10 5 cells/well) were pre-treated with vaspin (100 ng/ml) for 24 h and then incubated with ox-LDL (50 µg/ml) for 24 or 48 h. The cells were then harvested and resuspended in binding buffer, followed by double staining with fluorescein isothiocyanate-conjugated Annexin V (20 µg/ml; 5 µl) and propidium iodide (50 µg/ml; 5 µl) for 15 min at 20˚C, in Ca 2+ -enriched binding buffer. Fluorescence was detected by FACScan flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA).
Terminal deoxyribonucleotide transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) assay.
The TUNEL assay was performed using an In Situ Cell Death Detection kit (Roche Diagnostics, Mannheim, Germany). Macrophages were pretreated with vaspin (100 ng/ml) for 24 h and then stimulated with ox-LDL (50 µg/ml) for 48 h. The macrophages were subsequently fixed with 4% paraformaldehyde for 25 min, followed by permeabilization with 0.2% Triton X-100 for 5 min. Finally, the macrophages were incubated with TUNEL reaction mixture for 1 h at 37˚C in the dark, and stained with Hoechst 33342 (Invitrogen; Thermo Fisher Scientific, Inc.) for 20 min. The fluorescence images were obtained using a fluorescence microscope (Leica DMI6000; magnification, x50). The number of TUNEL-positive cells was expressed as a percentage of positive cells double-stained with TUNEL and Hoechst 33342.
Protein extraction and western blot analysis. Protein extraction and western blot analysis were performed as described in our previous study (21) . Cells were lysed with ice-cold radioimmunoprecipitation assay buffer (Santa Cruz Biotechnology, Inc.) and centrifuged at 10,000 x g for 5 min at 4˚C. Protein concentrations in the supernatants were measured using a Bicinchoninc Acid Protein Assay kit (Pierce Biotechnology, Inc., Rockford, IL, USA). Briefly, protein samples (20 µg) were separated by 10 or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes (CW Biotech, Beijing, China). The membranes were blocked with 5% BSA for 1 h and were then incubated with the following antibodies at 4˚C overnight: Anti-activating transcription factor (ATF)6 (1:1,000; ProteinTech Group, Inc., Chicago, IL, USA; cat. no. 24169-AP), anti-CHOP (1:1,000), anti-total (t)-c-Jun N-terminal kinases (JNK)1/2 (1:800; Cell Signaling Technology, Inc., cat. no. 9258, anti-phosphorylated (p)-JNK1/2 (1:800; Cell Signaling Technology, Inc.; cat. no. 4671), anti-cleaved-caspase 12 (1:800; BioVision, Inc., Milpitas, CA, USA; cat. no. 3282-100), anti-cleaved-caspase 9 (1:800; Abcam, Cambridge, MA, USA; cat. no. ab2325) and anti-cleaved-caspase 3 (1:800; Abcam; cat. no. ab2302).
Anti-b-actin served as the control antibody (1:5,000; Shanghai Yeasen Biotechnology Co., Ltd., Shanghai, China; cat. no. 30101ES50) The membranes were then washed with PBST and incubated with horseradish peroxidase-conjugated anti-rabbit immunoglobulin G (IgG) secondary antibody (1:2,000; GE Healthcare Life Sciences, Chalfont, UK; cat. no. NA9310) or anti-mouse IgG secondary antibodies (1:2,000; GE Healthcare Life Sciences; NA931) for 1 h, and were visualized using an Odyssey Imaging system (LI-COR Biosciences, Lincoln, NE, USA).
Statistical analysis. All statistical analyses were performed using SPSS 14.0 (SPSS, Inc., Chicago, IL, USA). Data are presented as the mean ± SEM. Differences between two groups were examined using Student's t-test. One-way analysis of variance was used to compare multiple groups, if appropriate, with Bonferroni correction for the post-hoc analysis. P<0.05 was considered to indicate a statistically significant difference, and P≤0.016 was considered to indicate a statistically significant difference for post-hoc analysis. All experiments were performed at least three times.
Results

Vaspin inhibits the progression of atherosclerosis in apoE
-/-mice. Body weight and food intake of the apoE -/-mice were not influenced by LV5-mus-vaspin transfection during the 12-week feeding regimen (Fig. 1A) . There was no difference between the LV5NC and LV5-mus-vaspin-transfected groups in circulating levels of triglyceride, LDL-C, HDL-C and glucose; however, the total cholesterol level was markedly decreased in the LV5-mus-vaspin-transfected mice (27.12±1.39 vs. 33.04±1.70 mmol/l; P<0.001; n=8; Fig. 1B ). Whole aortas, from the ascending aorta to the abdominal aorta, were cut open, periaortic fat and blood clots were removed, and the vessels were longitudinally sectioned and stained with Oil Red O, in order to detect lipid deposition. The lesions were then measured as a percentage of plaque area. As shown in Fig. 1C , LV5-mus-vaspin-transfected apoE -/-mice exhibited significantly reduced lesion development, as compared with the LV5NC-transfected group (plaque area 11.03±1.34 vs. 34.74±1.98%; P<0.001; n=5).
To confirm that the apoE -/-mice were successfully transfected with the lentiviruses, immunohistochemical staining of GFP and vaspin was conducted in the aortic sinus of the C57BL/6 mice, LV5NC-transfected apoE -/-mice (negative control), and LV5-mus-vaspin-transfected mice. As shown in Fig. 2C , the expression of GFP was higher in the LV5-mus-vaspin-transfected apoE -/-mice, as compared with the C57BL/6 mice. In addition, the expression of vaspin was increased in the LV5-mus-vaspin-transfected apoE -/-mice, as compared with the LV5NC-transfected group and C57BL/6 mice.
Vaspin decreases atherosclerotic plaque size and attenuates ER stress in apoE
-/-mice. Masson's trichrome staining was used to evaluate plaque stabilization. Vaspin markedly enhanced collagen content, whereas the lipid-rich necrotic core size was significantly decreased following vaspin transfection (P<0.01; Fig. 2A) . Considering other aspects of plaque composition, an immunohistochemical analysis detected reduced CHOP expression in the aortic sinus of LV5-mus-vaspin-transfected apoE -/-mice (P<0.001; Fig. 2B ).
Vaspin inhibits ER stress-induced apoptosis in macrophages.
To confirm the inhibitory effects of vaspin on ER stress-induced apoptosis, Annexin V/propidium iodide dual staining and FCM, and TUNEL analyses were performed. Representative images from the FCM assays and summarized data are shown in Fig. 3A . (Fig. 3B) .
Vaspin downregulates the expression of proteins associated with ER stress-induced apoptosis in macrophages.
As shown in Fig. 4A and B, ATF6, CHOP, t-JNK1/2, cleaved-caspase 12, cleaved-caspase 9 and cleaved-caspase 3 were overexpressed in response to ox-LDL (50 µg/ml) incubation but were markedly suppressed by vaspin pretreatment (100 ng/ml). Western blotting was performed to confirm the that vaspin inhibited the progression of atherosclerotic plaques via downregulation of proteins associated with ER stress-induced apoptosis.
Discussion
The results of the present study demonstrated that vaspin was able to inhibit the progression of atherosclerotic plaques in apoE -/-mice. The underlying protective mechanism was partly associated with the inhibition of ER stress-induced macrophage apoptosis. Vaspin is well known for its ability to improve insulin sensitivity (1, 2) . Numerous studies regarding vaspin, including our previous study, have demonstrated that vaspin exerts anti-inflammatory and beneficial effects in cardiovascular disease, in addition to its protective role in metabolic disease (10, 12, 22) . As well as our previous study (10), Phalitakul et al (23) reported that vaspin has an inhibitory role on VSMC inflammation by affecting inflammatory signaling pathways. In addition, Jung et al demonstrated that vaspin may protect vascular endothelial cells against free fatty acid-induced apoptosis via upregulation of the phosphoinositide 3-kinase/Akt signaling pathway (9) .
The results of the present study demonstrated that vaspin was able to inhibit ER stress-induced macrophage apoptosis. In addition, vaspin inhibited ER stress and apoptosis in vivo, as detected by reductions in the expression levels of CHOP in the aortic sinus following injection with a vaspin-encoding lentivirus. Notably, total cholesterol, but not serum glucose or lipid 
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levels, was significantly altered by vaspin, thus suggesting that the inhibitory effects of vaspin on lesion growth may be largely independent of lipid profile changes. However, the mechanisms underlying the antiapoptotic effects of vaspin on macrophages remain unclear. Nakatsuka et al (11, 12) reported that vaspin is a ligand for the cell surface-associated GRP78/MTJ-1 complex in the liver, and is a novel ligand for the cell surface GRP78/VDAC complex in endothelial cells, promoting proliferation, inhibiting apoptosis, and protecting against diabetes-induced vascular injury. The function of GRP78 is largely associated with the ER of cells. Nakatsuka et al was first to clarify the mechanisms underlying the antiapoptotic action of vaspin in vascular endothelial cells, and implied that vaspin may have a positive role against ER stress. It is well known that prolonged ER stress leads to cell death via apoptosis, and numerous apoptotic pathways have been identified. One apoptotic pathway is associated with the transcriptional induction of CHOP, which is a member of the C/EBP family of transcription factors (24) that can be induced by ATF6 (16) . Under normal conditions, CHOP is either not expressed or expressed at low levels; however, it is markedly activated in response to ER stress (25) . CHOP overexpression 
A B
can induce apoptosis, and a previous study demonstrated that CHOP expression within atherosclerotic plaques exhibited a strong correlation with the stage of coronary artery lesion, with both parameters markedly increasing in plaques with vulnerable morphology (26) . Another pathway is associated with the activation of JNK, which comprises a family of signal transduction proteins that regulate gene expression and participate in decisions regarding apoptosis and survival in response to stress (24) . The results of the present study demonstrated that the expression levels of ATF6, CHOP and JNK1/2 were significantly inhibited by vaspin, and CHOP expression and necrotic area were decreased in the atherosclerotic plaques of vaspin-transfected apoE -/-mice. These results confirmed that vaspin was able to inhibit the progression of atherosclerosis by suppressing ER stress-induced macrophage apoptosis in apoE -/-mice. Zhou et al demonstrated that macrophages accumulated in atherosclerotic lesions undergoing ER stress, and CHOP expression was increased during the progression of atherosclerosis in chow-fed or Western diet-fed apoE -/-mice (27) . These data indicated that CHOP expression increases as lesions progress, a concept that has been expanded to human atherosclerosis by Myoishi et al (26) . In addition, a previous study reported that CHOP deficiency suppressed atherosclerotic progression in apoE -/-mice, which is consistent with the results of the present study, and confirmed that the mechanism underlying atherosclerotic inhibition via CHOP deficiency is associated with decreased atherosclerotic plaque necrosis and apoptosis of macrophages (28) . CHOP-mediated macrophage apoptosis also contributes to the instability of atherosclerotic plaques, thus suggesting the importance of CHOP in macrophages (29) .
ER stress may also lead to apoptosis via activation of caspase 12 (24) . Caspase 12 is specifically activated in cells undergoing ER stress. Furthermore, caspase 12-deficient cells are resistant to ER stress inducers, suggesting that caspase-12 is significant in ER stress-induced apoptosis (30) . Upon ER stress, procaspase 12 is cleaved and activated, which in turn activates caspase 9/3, thereby leading to cell death (31) . The present study demonstrated that the expression levels of caspase 12, caspase 9 and caspase 3 were decreased by vaspin pretreatment. Furthermore, vaspin suppressed ER stress-induced apoptosis, as determined by FCM analysis and TUNEL assay.
In conclusion, the results of the present study indicated that vaspin was able to inhibit the progression of atherosclerotic plaques in apoE -/-mice. The potential underlying mechanism is partly associated with the inhibition of ER stress-induced macrophage apoptosis. These findings confirmed that vaspin may have a beneficial role in ameliorating the progression of atherosclerosis, and provide novel insights into the protective function of vaspin in atherosclerosis, thus suggesting that vaspin may be potentially useful for preventing vascular, as well as metabolic, diseases.
